Pfizer Stock Down After Announcing Mylan Deal

Pfizer Stock Down After Announcing Mylan Deal

Todd Peters, senior vice president at Adviser Investments, has the market analysis for Monday, July 29. U.S. indexes closed with mixed results: The Dow Jones Industrial Average rose 0.1% while the S&P 500 and NASDAQ Composite fell 0.1% and 0.4%, The Federal Reserve is set to cut rates for first time since 2008 in hopes of preventing a potential downturn in the economy. In the market, Pfizer’s stock announced merging its Upjohn business with Mylan. The stock was down 3% though, due to shortcomings in revenue estimates.

Recent Videos

View All Videos

Lowell on CNBC: Nervous Markets Call for a Balanced, Disciplined Investment Approach

Lowell on CNBC: Perspective on Dow’s 800-Point Drop

Stock Indexes Decline 3% but Long-Term Prospects Remain Strong

Lowell on CNBC: Current Market Offers Long-Term Opportunity

85 Wells Avenue, Suite 109 Newton, MA, 02459

info@adviserinvestments.com 1.800.492.6868

Adviser Investments' logo is a registered trademark of Adviser Investments, LLC.